Liminal Biosciences Net Tangible Assets

Liminal Biosciences (LMNL) currently reports a net tangible assets of $21M as of June 2023. That compares with $18M in the prior-year period — up 21.7% year over year. Use the charts on this page to explore Liminal Biosciences's net tangible assets history and peer comparisons.

Liminal Biosciences's net tangible assets increased from $18M to $21M — a 21.7% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Liminal Biosciences reported $21M in net tangible assets as of June 2023. That compares with $18M in the prior-year period — up 21.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Liminal Biosciences, and consider following LMNL for alerts when major investors trade the stock.

Liminal Biosciences is classified in the Healthcare sector. On net tangible assets, it currently shows $21M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LMNL with unrelated industries.